Novavax
NVAX
151 hedge funds and large institutions have $327M invested in Novavax in 2018 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 16 closing their positions.
113% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 16
108% more capital invested
Capital invested by funds: $157M → $327M (+$170M)
24% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 38
21% more call options, than puts
Call options by funds: $4.3M | Put options by funds: $3.54M
13% more funds holding
Funds holding: 134 → 151 (+17)
0.24% more ownership
Funds ownership: 2.02% → 2.26% (+0.24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$26.4M |
| 2 |
Millennium Management
New York
|
+$8.25M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.55M |
| 4 |
Renaissance Technologies
New York
|
+$5.97M |
| 5 |
RI
RTW Investments
New York
|
+$5.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.58M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.34M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.31M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$2.2M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.07M |
NVAX Hedge Fund Activity: Q1 2018 in Review
151 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2018, worth a combined $327M — up 108% from $157M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new NVAX positions and 16 closed out — a net gain of 18 holders — while 47 added to existing stakes and 38 trimmed.
The largest buyer was State Street, adding an estimated $26.4M. The largest seller was Citadel Advisors, cutting an estimated $2.58M.
- 151 institutional investors held Novavax (NVAX) as of Q1 2018, up from 134 in Q4 2017.
- Funds reported $327M of Novavax stock for Q1 2018, up 108% quarter-over-quarter.
- 34 funds opened new Novavax positions in Q1 2018 and 16 closed out, a net change of +18 holders.
- The largest Novavax buyer in Q1 2018 was State Street, an estimated $26.4M added.
- The largest Novavax seller in Q1 2018 was Citadel Advisors, an estimated $2.58M sold.
Based on aggregated 13F filings for Q1 2018.